Next Article in Journal
FGFR2-Rearranged Biliary Tract Cancer: Biology, Resistance Mechanisms, and Emerging Therapeutic Strategies
Previous Article in Journal
Age-Specific ADHD and Internalizing/Externalizing Comorbidity in Children with Neurofibromatosis Type 1: A Multi-Site Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 18
Issue 3
10.3390/cancers18030530
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Cancers 2021, 13(15), 3876.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Wu et al. WIP1 Inhibition by GSK2830371 Potentiates HDM201 Through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers 2021, 13, 3876

by
Chiao-En Wu
1,2,†,
Ahmed Khairallah Mahdi
3,4,†,
Chen-Yang Huang
1,
Chiao-Ping Chen
1,2,
Yi-Ru Pan
2,5,
John Wen-Cheng Chang
1,
Jen-Shi Chen
1,
Chun-Nan Yeh
2,5,* and
John Lunec
4,*
1
Division of Haematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou Branch, Chang Gung University College of Medicine, Taoyuan 333, Taiwan
2
Liver Research Center, Chang Gung Memorial Hospital, Linkou, Taoyuan 333, Taiwan
3
Department of Pathology and Forensic Medicine, College of Medicine, Al-Nahrain University, Baghdad 10006, Iraq
4
Newcastle University Cancer Centre, Bioscience Institute, Medical Faculty, Newcastle University, Newcastle upon Tyne NE2 4HH, UK
5
Department of General Surgery, Chang Gung Memorial Hospital, Linkou Branch, Chang Gung University, Taoyuan 333, Taiwan
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Cancers 2026, 18(3), 530; https://doi.org/10.3390/cancers18030530
Submission received: 26 January 2026 / Accepted: 29 January 2026 / Published: 6 February 2026
Versions Notes

Missing Funding

In the original publication [1], funding from the Iraqi Ministry of Higher Education and Scientific Research to Ahmed Khairallah Mahdi was not included.

Addition of an Author

Ahmed Khairallah Mahdi was not included as an author in the original publication. The corrected Author Contributions statement appears here.
  • Author Contributions: Conceptualization, C.-E.W., A.K.M., C.-Y.H., C.-N.Y. and J.L.; Data curation, C.-E.W. and C.-P.C.; Formal analysis, C.-P.C. and Y.-R.P.; Funding acquisition, C.-E.W. and C.-N.Y.; Investigation, C.-P.C., Y.-R.P., J.W.-C.C. and J.-S.C.; Methodology, C.-E.W., A.K.M., C.-Y.H. and Y.-R.P.; Project administration, C.-E.W.; Supervision, J.L.; Validation, C.-E.W., C.-Y.H., C.-N.Y. and J.L.; Visualization, C.-P.C.; Writing—Original draft, C.-E.W.; Writing—Review and editing, C.-N.Y. and J.L. All authors have read and agreed to the published version of the manuscript.
Ahmed Khairallah Mahdi and Chiao-En Wu have equally contributed to the initiation, conceptualization and methodology of the study.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Wu, C.-E.; Mahdi, A.K.; Huang, C.-Y.; Chen, C.-P.; Pan, Y.-R.; Chang, J.W.-C.; Chen, J.-S.; Yeh, C.-N.; Lunec, J. WIP1 Inhibition by GSK2830371 Potentiates HDM201 through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers 2021, 13, 3876. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Wu, C.-E.; Mahdi, A.K.; Huang, C.-Y.; Chen, C.-P.; Pan, Y.-R.; Chang, J.W.-C.; Chen, J.-S.; Yeh, C.-N.; Lunec, J. Correction: Wu et al. WIP1 Inhibition by GSK2830371 Potentiates HDM201 Through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers 2021, 13, 3876. Cancers 2026, 18, 530. https://doi.org/10.3390/cancers18030530

AMA Style

Wu C-E, Mahdi AK, Huang C-Y, Chen C-P, Pan Y-R, Chang JW-C, Chen J-S, Yeh C-N, Lunec J. Correction: Wu et al. WIP1 Inhibition by GSK2830371 Potentiates HDM201 Through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers 2021, 13, 3876. Cancers. 2026; 18(3):530. https://doi.org/10.3390/cancers18030530

Chicago/Turabian Style

Wu, Chiao-En, Ahmed Khairallah Mahdi, Chen-Yang Huang, Chiao-Ping Chen, Yi-Ru Pan, John Wen-Cheng Chang, Jen-Shi Chen, Chun-Nan Yeh, and John Lunec. 2026. "Correction: Wu et al. WIP1 Inhibition by GSK2830371 Potentiates HDM201 Through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers 2021, 13, 3876" Cancers 18, no. 3: 530. https://doi.org/10.3390/cancers18030530

APA Style

Wu, C.-E., Mahdi, A. K., Huang, C.-Y., Chen, C.-P., Pan, Y.-R., Chang, J. W.-C., Chen, J.-S., Yeh, C.-N., & Lunec, J. (2026). Correction: Wu et al. WIP1 Inhibition by GSK2830371 Potentiates HDM201 Through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers 2021, 13, 3876. Cancers, 18(3), 530. https://doi.org/10.3390/cancers18030530

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop